Funding for this research was provided by:
Rheumatology Research Foundation (Scientist Development Award)
Cincinnati Children’s Research Foundation (Procter Scholar Award)
Received: 17 November 2017
Accepted: 11 January 2018
First Online: 9 February 2018
Ethics approval and consent to participate
: This study was approved by the Cincinnati Children’s Hospital Institutional Review Board (IRB 2011-1517), and informed consent was obtained from all patients and/or their legal guardians.
: Consent for publication was obtained from all patients and/or their legal guardians.
: Dr. Schulert has received consulting fees from Novartis. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.